Does Vitamin K2 Bone Health Randomized Trial work?

Updated May 2026

Quick Answer

Vitamin K2 Bone Health Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Vitamin D deficiency has been consistently associated with adverse outcomes, including increased susceptibility to cancers, diabetes, hypertension, and cardiovascular disease [,].

Key Takeaways

  • 01Vitamin D deficiency has been consistently associated with adverse outcomes, including increased susceptibility to cancers, diabetes, hypertension, and cardiovascular disease [,]. [D’Elia Saverio (2025)]
  • 02Epidemiological studies further indicate that populations in regions with higher sun exposure exhibit lower prevalence of deficiency and reduced mortality from chronic disease [,]. [D’Elia Saverio (2025)]
  • 03These findings are reinforced by recent large-scale analyses: for example, a 2023 study in Clinical Nutrition involving nearly 410,000 UK Biobank participants reported that individuals with severe deficiency (<30 nmol/L) had a 10% increased risk of atherosclerotic cardiovascular disease and up to 35% higher risk of cardiovascular mortality []. [D&#8217;Elia Saverio (2025)]
  • 041 2 3 4 5 6 7 6 Vitamin D, a pleiotropic secosteroid, exerts physiological effects far beyond its classical roles in calcium homeostasis and skeletal health []. [D&#8217;Elia Saverio (2025)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin K2 Bone Health Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Vitamin D deficiency has been consistently associated with adverse outcomes, including increased susceptibility to cancers, diabetes, hypertension, and cardiovascular disease [,]. [D&#8217;Elia Saverio (2025); evidence level 3] - Epidemiological studies further indicate that populations in regions with higher sun exposure exhibit lower prevalence of deficiency and reduced mortality from chronic disease [,]. [D&#8217;Elia Saverio (2025); evidence level 3] - These findings are reinforced by recent large-scale analyses: for example, a 2023 study in Clinical Nutrition involving nearly 410,000 UK Biobank participants reported that individuals with severe deficiency (<30 nmol/L) had a 10% increased risk of atherosclerotic cardiovascular disease and up to 35% higher risk of cardiovascular mortality []. [D&#8217;Elia Saverio (2025); evidence level 3] - 1 2 3 4 5 6 7 6 Vitamin D, a pleiotropic secosteroid, exerts physiological effects far beyond its classical roles in calcium homeostasis and skeletal health []. [D&#8217;Elia Saverio (2025); evidence level 3] - 14 15 11 12 16 17 18 Epidemiological studies support this notion, reporting that higher vitamin K status is associated with better physical performance and lower risk of mobility limitation in older adults (,). [Ran Xiaoyu (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties
  2. Vitamin K and muscle health: mechanisms and clinical perspectives in sarcopenia and beyond: narrative review